MARKET

ADCT

ADCT

Adc Therapeutics Sa
NYSE
1.490
-0.030
-1.97%
After Hours: 1.520 +0.03 +2.01% 17:47 03/28 EDT
OPEN
1.480
PREV CLOSE
1.520
HIGH
1.495
LOW
1.440
VOLUME
253.25K
TURNOVER
--
52 WEEK HIGH
5.38
52 WEEK LOW
1.390
MARKET CAP
144.07M
P/E (TTM)
-0.6210
1D
5D
1M
3M
1Y
5Y
1D
ADC Therapeutics Earnings Call: Optimism Amid Challenges
TipRanks · 1d ago
ADC Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St · 1d ago
ADC Therapeutics (ADCT) Gets a Buy from RBC Capital
TipRanks · 1d ago
ADC Therapeutics Reports Strong 2024 Financials and Trial Progress
TipRanks · 2d ago
ADC Therapeutics SA Annual Report (Form 10-K) for the fiscal year ended December 31, 2024
Press release · 2d ago
ADC Therapeutics targets $600M–$1B in peak ZYNLONTA revenue amid expansion into DLBCL market
Seeking Alpha · 2d ago
Morning Movers: Nvidia slips following report of H20 chip shortage in China
TipRanks · 2d ago
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue Estimates
NASDAQ · 2d ago
More
About ADCT
More
ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.
Recently
Symbol
Price
%Change

Webull offers ADC Therapeutics SA stock information, including NYSE: ADCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADCT stock methods without spending real money on the virtual paper trading platform.